NCT06285942View on ClinicalTrials.gov

EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation

NARecruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Atrial FibrillationFragility
Interventions
DRUG

Edoxaban

To use of Edoxaban via PEG in patients with an indication to anticoagulation therapy according to current guidelines

DRUG

No Edoxaban

Other DOACs through PEG or subcutaneous heparin or LMWH

Trial Locations (3)

16132

RECRUITING

Ospedale Policlinico San Martino, Genova

28100

RECRUITING

AOU Maggiore della Carità, Novara

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

All Listed Sponsors
lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER